1,467 results on '"Bartlett, David L."'
Search Results
2. Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent: Final Results from a Phase II Study
3. Advanced Care Planning Prior to Oncologic Surgery: An Assessment of Utilization and Implications
4. Exploring the Perception of Value in Cancer Care: A Comparison of Patients, Providers, and Payers
5. Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases
6. Characterizing the Immune Environment in Peritoneal Carcinomatosis: Insights for Novel Immunotherapy Strategies
7. Cover
8. Frontmatter
9. 6. Structural Adjustment in Hungary's New Democracy
10. Index
11. 5. Stabilization Policy in the Postcommunist Period
12. 7. Implications and Comparative Perspectives
13. Part 3: Economic Reform in Democratic Hungary, 1990−94
14. Part 4: Conclusions
15. 2. Macroeconomic Stabilization under Reform Communism
16. Appendix
17. 4. Political Institutions and Hungary's Negotiated Transition
18. Part 2: Economic Reform in Communist Hungary, 1979−89
19. 3. Structural Adjustment and Market Socialism
20. Part 1: An Institutional Approach to Eastern Europe's Transition
21. 1. Party and State Institutions in Dual Transformations
22. Tables
23. Correction: Exploring the Perception of Value in Cancer Care: A Comparison of Patients, Providers, and Payers
24. ASO Visual Abstract: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent—Final Results from a Phase 2 Study
25. ASO Visual Abstract: Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases
26. Microsatellite instability should not determine candidacy for cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion in patients with peritoneal metastases from colorectal cancer
27. Defining the Values and Quality of Life of Cancer Survivors Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An International Survey Study
28. Targeted Next-Generation Sequencing Improves the Prognostication of Patients with Disseminated Appendiceal Mucinous Neoplasms (Pseudomyxoma Peritonei)
29. ASO Visual Abstract: Characterizing the Immune Environment in Peritoneal Carcinomatosis—Insights for Novel Immunotherapy Strategies
30. Intra-pleural and intra-peritoneal tocilizumab therapy for managing malignant pleural effusions and ascites: The Regional Immuno-Oncology Trial (RIOT)−2 study protocol
31. Intra-tumoral immunomodulatory therapy for advanced abdominal cancers using lipopolysaccharide: The Regional Immuno-Oncology Trial-1 (RIOT-1) protocol (NCT05751837)
32. Predicting Severe Complications from Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: A Data-Driven, Machine Learning Approach to Augment Clinical Judgment
33. Assessing the long-term priorities of pancreaticoduodenectomy survivors
34. Comprehensive value implications of surgeon volume for lung cancer surgery: Use of an analytic framework within a regional health system
35. Socioeconomic Factors Predict Long-Term Quality of Life of Cancer Survivors: An International Survey
36. Impact of Primary Tumor Location and Genomic Alterations on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Colorectal Peritoneal Metastases
37. ASO Visual Abstract: Targeted Next-Generation Sequencing Improves the Prognostication of Patients with Disseminated Appendiceal Mucinous Neoplasms (Pseudomyxoma Peritonei)
38. ASO Visual Abstract: Defining the Values and Quality of Life of Cancer Survivors Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An International Survey Study
39. ASO Visual Abstract: Impact of Primary Tumor Location and Genomic Alterations on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Colorectal Peritoneal Metastases
40. ASO Author Reflections: Augmenting Clinical Decision-Making Around Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Through Traditional and Machine Learning Algorithms
41. Failure to Thrive Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy: Causes and Consequences
42. ASO Visual Abstract: Predicting Severe Complications from Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy—A Data-Driven, Machine Learning Approach to Augment Clinical Judgement
43. Long‐term patient‐reported values following cancer surgery: A global survey study.
44. Novel Techniques and the Future of HIPEC (Immunotherapy, Viral Therapy)
45. Impact of Neoadjuvant Therapy on Survival Following Margin-Positive Resection for Pancreatic Cancer
46. Optimal Management of Resectable Pancreatic Head Cancer in the Elderly Patient: Does Neoadjuvant Therapy Offer a Survival Benefit?
47. Predischarge Prediction of Readmission After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Derivation and Validation of a Risk Prediction Score
48. IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity
49. Improved chemosensitivity following mucolytic therapy in patient-derived models of mucinous appendix cancer
50. Phase II Trial of Adjuvant Dendritic Cell Vaccine in Combination with Celecoxib, Interferon-α, and Rintatolimod in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.